BCL11B
BCL11B,即B細胞淋巴瘤/白血病11B基因,別名CTIP2、RIT1。BCL11B在T細胞發育和身份維持中有重要作用,最初被發現是輻射引發的T細胞淋巴瘤的潛在抑制因子。BCL11B的作用機制涉及抑制NuRD復合物和促進β-catenin與TCF4的相互作用來激活Wnt信號,其表達直接被BMP信號所抑制。BCL11B在T細胞急性淋巴細胞白血病(T-ALL)中作為單倍劑量不足的抑癌因子,與其他致癌病變聯合發揮作用。BCL11B還與神經發育有關,其在少突膠質細胞分化過程中的表達降低,但對神經元分化和中樞神經系統的發育具有調節作用。BCL11B的異常表達與多種疾病相關,包括T-ALL和某些神經發育障礙。
熱銷產品
Recombinant Human B-cell lymphoma/leukemia 11B (BCL11B), partial (CSB-EP880159HU)
驗證數據

(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
BCL11B Antibody (CSB-PA880159HA01HU)
驗證數據

Immunohistochemistry of paraffin-embedded human brain tissue using CSB-PA880159HA01HU at dilution of 1:300
BCL11B Antibodies
BCL11B for Homo sapiens (Human)
產品貨號 | 產品名稱 | 種屬反應性 | 應用類型 |
---|---|---|---|
CSB-PA880159HA01HU | BCL11B Antibody | Human | ELISA, IHC |
CSB-PA880159HC01HU | BCL11B Antibody, FITC conjugated | Human |
BCL11B Proteins
BCL11B Proteins for Homo sapiens (Human)
產品貨號 | 產品名稱 | 來源 |
---|---|---|
CSB-YP880159HU CSB-BP880159HU CSB-MP880159HU CSB-EP880159HU-B |
Recombinant Human B-cell lymphoma/leukemia 11B (BCL11B), partial | Yeast Baculovirus Mammalian cell In Vivo Biotinylation in E.coli |
CSB-EP880159HU | Recombinant Human B-cell lymphoma/leukemia 11B (BCL11B), partial | E.coli |